Eslicarbazepine Acetate
Eslicarbazepine Acetate (Zebinix) is an anticonvulsant medication approved for use in Europe, the United States and Canada as an adjunctive therapy for partial-onset seizures that are not adequately controlled with conventional therapy.

Catalog Number | T3285 |
Alternative Name(s) | Zebinix , Aptiom , BIA 2-093 , Exalief , Stedesa |
Research Area | Membrane transporter/Ion channel|||Neuroscience |
Molecular Formula | C17H16N2O3 |
CAS# | 236395-14-5 |
Purity | 100.00% |
SMILES | c12c(cccc1)N(c1ccccc1C[C@@H]2OC(=O)C)C(=O)N |
Size | 10 mg |
Supplier Page | https://www.targetmol.com/compound/Eslicarbazepine Acetate |
Additional Information | https://www.targetmol.com/datasheet/T3285 |